TY - JOUR
T1 - Trends of primary liver cancer incidence and mortality in the United States
T2 - A population-based study over the last four decades
AU - Adra, Saryia
AU - Alabrach, Yousef
AU - Hashem, Anas
AU - Mahmoud, Amir
AU - Khalouf, Amani
AU - El-Khapery, Ahmed
AU - Abdelhay, Ali
AU - Mansour, Mohamad
AU - Aldaher, Batool
AU - Barqawi, Hiba
AU - Abu-Gharbieh, Eman
N1 - Publisher Copyright:
© 2024 Adra et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2024/9
Y1 - 2024/9
N2 - Background Primary liver cancer is the third leading cause of cancer deaths worldwide and has one of the worst 5-year survival rates. This study examines US primary liver cancer incidence and incidence-based mortality trends over four decades. Research design and methods The SEER-9 registry was used to study primary liver cancer cases from 1978 to 2018. The incidence and mortality rates were calculated based on gender, age, race, and stage of diagnosis. Joinpoint regression software was used to calculate the annual percent change. Results The overall incidence rate of primary liver cancer from 1978 to 2018 increased by 2.71%/ year (p<0.001). Rates in patients <50 years old began to fall in 2002 at a rate of -3.62%/year (p<0.001). Similarly, the incidence-based mortality rates for primary liver cancer increased by 2.15%/year (p<0.001). Whereas Whites incidence-based mortality rates began to plateau in 2012 (0.18%/year; p = 0.84), Blacks rates have declined since 2010 (-2.93%/year; p = 0.03), and Asian rates have declined since 1999 (-1.30%/year; p<0.001). Conclusion While the overall primary liver cancer incidence and incidence-based mortality have been increasing over the last four decades, there was an observed decline in incidence and incidence-based mortality in recent years, especially among at-risk subgroups.
AB - Background Primary liver cancer is the third leading cause of cancer deaths worldwide and has one of the worst 5-year survival rates. This study examines US primary liver cancer incidence and incidence-based mortality trends over four decades. Research design and methods The SEER-9 registry was used to study primary liver cancer cases from 1978 to 2018. The incidence and mortality rates were calculated based on gender, age, race, and stage of diagnosis. Joinpoint regression software was used to calculate the annual percent change. Results The overall incidence rate of primary liver cancer from 1978 to 2018 increased by 2.71%/ year (p<0.001). Rates in patients <50 years old began to fall in 2002 at a rate of -3.62%/year (p<0.001). Similarly, the incidence-based mortality rates for primary liver cancer increased by 2.15%/year (p<0.001). Whereas Whites incidence-based mortality rates began to plateau in 2012 (0.18%/year; p = 0.84), Blacks rates have declined since 2010 (-2.93%/year; p = 0.03), and Asian rates have declined since 1999 (-1.30%/year; p<0.001). Conclusion While the overall primary liver cancer incidence and incidence-based mortality have been increasing over the last four decades, there was an observed decline in incidence and incidence-based mortality in recent years, especially among at-risk subgroups.
UR - https://www.scopus.com/pages/publications/85203279340
U2 - 10.1371/journal.pone.0309465
DO - 10.1371/journal.pone.0309465
M3 - Article
C2 - 39236039
AN - SCOPUS:85203279340
SN - 1932-6203
VL - 19
JO - PloS one
JF - PloS one
IS - 9 September
M1 - e0309465
ER -